A classification tree approach for pituitary adenomas

It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index h...

Full description

Saved in:
Bibliographic Details
Published inHuman pathology Vol. 43; no. 10; pp. 1627 - 1637
Main Authors Righi, Alberto, Agati, Patrizia, Sisto, Andrea, Frank, Giorgio, Faustini-Fustini, Marco, Agati, Raffaele, Mazzatenta, Diego, Farnedi, Anna, Menetti, Federico, Marucci, Gianluca, Foschini, Maria P.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.10.2012
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis–derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors.
AbstractList It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis-derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors.It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis-derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors.
It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis-derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors.
Summary It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis–derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors.
Author Faustini-Fustini, Marco
Farnedi, Anna
Frank, Giorgio
Menetti, Federico
Agati, Raffaele
Foschini, Maria P.
Sisto, Andrea
Agati, Patrizia
Mazzatenta, Diego
Righi, Alberto
Marucci, Gianluca
Author_xml – sequence: 1
  givenname: Alberto
  surname: Righi
  fullname: Righi, Alberto
  organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy
– sequence: 2
  givenname: Patrizia
  surname: Agati
  fullname: Agati, Patrizia
  organization: Department of Statistics “P. Fortunati,” University of Bologna, 40126 Bologna, Italy
– sequence: 3
  givenname: Andrea
  surname: Sisto
  fullname: Sisto, Andrea
  organization: University of Eastern Piedmont, Polis-Public Policy and Choice, 15121 Alessandria, Italy
– sequence: 4
  givenname: Giorgio
  surname: Frank
  fullname: Frank, Giorgio
  organization: Center of Surgery for Pituitary Tumors, Bellaria Hospital, 10126 Bologna, Italy
– sequence: 5
  givenname: Marco
  surname: Faustini-Fustini
  fullname: Faustini-Fustini, Marco
  organization: Endocrine Unit, Department of Medicine, Bellaria Hospital, 10126 Bologna, Italy
– sequence: 6
  givenname: Raffaele
  surname: Agati
  fullname: Agati, Raffaele
  organization: Department of Neuroradiology, Bellaria Hospital, 40139 Bologna, Italy
– sequence: 7
  givenname: Diego
  surname: Mazzatenta
  fullname: Mazzatenta, Diego
  organization: Center of Surgery for Pituitary Tumors, Bellaria Hospital, 10126 Bologna, Italy
– sequence: 8
  givenname: Anna
  surname: Farnedi
  fullname: Farnedi, Anna
  organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy
– sequence: 9
  givenname: Federico
  surname: Menetti
  fullname: Menetti, Federico
  organization: Department of Neuroradiology, Bellaria Hospital, 40139 Bologna, Italy
– sequence: 10
  givenname: Gianluca
  surname: Marucci
  fullname: Marucci, Gianluca
  organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy
– sequence: 11
  givenname: Maria P.
  surname: Foschini
  fullname: Foschini, Maria P.
  email: mariapia.foschini@ausl.bo.it, mariapia.foschini@unibo.it
  organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26426067$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22446019$$D View this record in MEDLINE/PubMed
BookMark eNqNkt2L1DAUxYOsuLOrf4JSEMGX1iRt0xZRWRa_YMEH9TncubllMvbLpBX2v_eWGV0YkPUpefidw8k5uRBnwziQEE-VzJRU5tU-2y39BPMu01KpTOlMyvyB2Kgy12mdN_pMbKQsTFqrqjoXFzHuJYNlUT4S51oXhZGq2YjyKsEOYvStR5j9OCRzIEpgmsIIuEvaMSSTnxc_Q7hNwNEw9hAfi4ctdJGeHM9L8f3D-2_Xn9KbLx8_X1_dpMgp5rSEEhS1EmSJBrGlYusKBQi50eSMNAaNy6tCOdNuXY2ydrCtG3KuRVbq_FK8PPhymp8Lxdn2PiJ1HQw0LtEqaRotq6rIGX1-gu7HJQycjqlaMiZzw9SzI7Vse3J2Cr7nh9k_hTDw4ghAROjaAAP6eMeZQnPuirnywGEYYwzU_kWUtOtAdm-PA9l1IKu05QSse32iQ652LX4O4Lt71e8OauLSf3kKNqKnAcn5QDhbN_p7Hd6eOGDnB96--0G3FO86s5EF9uv6hdYfpBTfGlOywZt_G_xHgN8Bfdf7
CODEN HPCQA4
CitedBy_id crossref_primary_10_1007_s11102_017_0855_1
crossref_primary_10_1155_2016_7964523
crossref_primary_10_1016_j_otc_2015_09_004
crossref_primary_10_1111_jne_13263
crossref_primary_10_1530_EJE_17_0796
crossref_primary_10_1007_s11102_024_01414_y
crossref_primary_10_1530_EO_21_0026
crossref_primary_10_1007_s00701_014_1993_0
crossref_primary_10_1016_j_ecl_2014_10_001
crossref_primary_10_1530_EJE_15_0586
crossref_primary_10_1016_j_lpm_2021_104086
crossref_primary_10_5812_ijem_81983
crossref_primary_10_1016_j_humpath_2013_05_020
crossref_primary_10_1080_02688697_2024_2384748
crossref_primary_10_1007_s12022_016_9418_7
crossref_primary_10_3390_cancers12020514
crossref_primary_10_1016_j_ensci_2021_100317
crossref_primary_10_1530_EJE_17_0965
crossref_primary_10_1159_000375448
crossref_primary_10_1210_js_2019_00163
crossref_primary_10_1007_s00701_019_03879_4
crossref_primary_10_1016_j_clineuro_2016_03_021
crossref_primary_10_1530_EJE_15_1226
crossref_primary_10_1007_s12022_014_9322_y
crossref_primary_10_1016_j_endoen_2014_02_011
crossref_primary_10_1007_s10014_022_00441_6
crossref_primary_10_1007_s11060_016_2365_9
crossref_primary_10_1016_j_jbi_2017_08_005
crossref_primary_10_3390_diagnostics14030274
crossref_primary_10_1093_neuros_nyx541
crossref_primary_10_1155_2013_983953
crossref_primary_10_1016_j_ando_2015_04_007
crossref_primary_10_1186_s40478_015_0229_8
crossref_primary_10_1530_EJE_13_1031
crossref_primary_10_1016_j_ando_2015_04_003
crossref_primary_10_1007_s40618_020_01275_9
crossref_primary_10_3390_cancers13236134
crossref_primary_10_1111_nan_12568
crossref_primary_10_1210_clinem_dgad673
crossref_primary_10_1007_s11060_013_1349_2
crossref_primary_10_1055_s_0041_1735874
crossref_primary_10_1097_PAI_0000000000000303
crossref_primary_10_1111_cen_14197
crossref_primary_10_56782_pps_114
crossref_primary_10_1007_s00401_013_1084_y
crossref_primary_10_1016_j_wneu_2018_05_077
crossref_primary_10_1007_s11102_013_0500_6
crossref_primary_10_1210_jc_2017_00773
crossref_primary_10_1007_s12020_016_0940_7
crossref_primary_10_1016_j_endonu_2013_04_009
crossref_primary_10_2217_ije_2015_0011
Cites_doi 10.1677/ERC-07-0062
10.1590/S0100-879X2004000200011
10.1227/01.NEU.0000223437.51435.6E
10.1038/modpathol.2010.58
10.1007/s00401-005-1093-6
10.1111/j.1365-2559.2010.03495.x
10.1210/jc.2009-0471
10.1007/s00401-005-1105-6
10.1080/01621459.1958.10501452
10.1227/01.NEU.0000349930.66434.82
10.1017/S0317167100002614
10.1677/erc.0.0090103
10.1210/jc.2008-0126
10.1111/j.1365-2265.2006.02630.x
10.3346/jkms.2005.20.3.489
10.1227/00006123-198912000-00012
10.1054/bjoc.1999.1074
10.1177/002215540104900916
10.1080/01616412.1985.11739714
10.3171/jns.1993.78.5.0753
10.1097/00006123-200012000-00009
10.1007/BF03346512
10.1023/A:1012940929072
10.5858/2008-132-1231-PPPWDT
10.1016/j.humpath.2007.10.004
10.3171/jns.2002.96.2.0195
10.1530/eje.1.02298
10.1530/EJE-07-0099
10.1136/jcp.52.2.107
ContentType Journal Article
Copyright 2012 Elsevier Inc.
Elsevier Inc.
2015 INIST-CNRS
Copyright © 2012 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2012 Elsevier Inc.
– notice: Elsevier Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1016/j.humpath.2011.12.003
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-8392
EndPage 1637
ExternalDocumentID 2773222641
22446019
26426067
10_1016_j_humpath_2011_12_003
S0046817711004965
1_s2_0_S0046817711004965
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1CY
1P~
1RT
1~.
1~5
3O-
4.4
457
4CK
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQOH
AAQQT
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CAG
COF
DU5
EBS
EFJIC
EFKBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDY
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
J5H
K-O
KOM
L7B
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OG0
OS0
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSZ
SV3
T5K
UGJ
UHS
UNMZH
UV1
WUQ
X7M
Z5R
ZGI
~G-
3V.
7X7
8FI
AACTN
AFCTW
AFKRA
AFKWA
AJOXV
AMFUW
AZQEC
BENPR
FYUFA
GUQSH
M1P
M2O
RIG
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c532t-5a5a1ef0a05c6ccfe4bd41aca362ed6066c6d3741d6fbd8c08dab89eddfc5a123
IEDL.DBID .~1
ISSN 0046-8177
1532-8392
IngestDate Fri Jul 11 06:03:14 EDT 2025
Sun Jul 13 03:57:30 EDT 2025
Thu Apr 03 07:05:26 EDT 2025
Mon Jul 21 09:14:58 EDT 2025
Thu Apr 24 23:11:26 EDT 2025
Tue Jul 01 02:24:16 EDT 2025
Sun Apr 06 06:53:56 EDT 2025
Sun Feb 23 10:19:16 EST 2025
Tue Aug 26 16:33:13 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Ki-67
Prognosis
Pituitary adenoma
p53
Endocrinopathy
Biological marker
Anatomic pathology
TP53 Gene
Classification
Pituitary diseases
Ki67 antigen
Tree
Tumor suppressor gene
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2012 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-5a5a1ef0a05c6ccfe4bd41aca362ed6066c6d3741d6fbd8c08dab89eddfc5a123
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
content type line 14
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 22446019
PQID 1080920036
PQPubID 105547
PageCount 11
ParticipantIDs proquest_miscellaneous_1069207743
proquest_journals_1080920036
pubmed_primary_22446019
pascalfrancis_primary_26426067
crossref_primary_10_1016_j_humpath_2011_12_003
crossref_citationtrail_10_1016_j_humpath_2011_12_003
elsevier_sciencedirect_doi_10_1016_j_humpath_2011_12_003
elsevier_clinicalkeyesjournals_1_s2_0_S0046817711004965
elsevier_clinicalkey_doi_10_1016_j_humpath_2011_12_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-10-01
PublicationDateYYYYMMDD 2012-10-01
PublicationDate_xml – month: 10
  year: 2012
  text: 2012-10-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: Philadelphia
PublicationTitle Human pathology
PublicationTitleAlternate Hum Pathol
PublicationYear 2012
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Gejman, Swearingen, Hedley-Whyte (bb0060) 2008; 39
Nakabayashi, Sunada, Hara (bb0050) 2001; 49
Noh, Jeong, Lee, Kim, Kim, Lee (bb0075) 2009; 94
Losa, Franzin, Mangili (bb0080) 2000; 47
Scheithauer, Gaffey, Lloyd (bb0030) 2006; 59
Ogawa, Ikeda, Tominaga (bb0085) 2009; 32
Wierinckx, Auger, Devauchelle (bb0095) 2007; 14
Fusco, Zatelli, Bianchi (bb0065) 2008; 93
Wang, Qian, Rahman (bb0100) 2010; 56
Lloyd (bb0120) 2001; 54
Breiman, Friedman, Olshen, Stone (bb0145) 1984
Jaffrain-Rea, Di Stefano, Minniti (bb0045) 2002; 9
Dubois, Guyétant, Menei (bb0015) 2007; 157
Hsu, Hakim, Biller (bb0135) 1993; 78
Scarpa, Mantovani, Capelli (bb0125) 2010; 23
Pizarro, Oliveira, Coutinho, Ferreira (bb0025) 2004; 37
Knosp, Kitz, Perneczky (bb0130) 1989; 25
Kleinschmidt-DeMasters (bb0155) 2006; 111
Paek, Kim, Song (bb0055) 2005; 20
Auer, Clarici (bb0110) 1985; 7
Mastronardi, Guiducci, Spera, Puzzilli, Liberati, Maira (bb0090) 1999; 52
Asa (bb0115) 2008; 132
Lloyd, Kovacs, Young (bb0010) 2004
Filippella, Galland, Kujas (bb0040) 2006; 65
Al-Shraim, Asa (bb0150) 2006; 111
Meij, Lopes, Ellegala, Alden, Laws (bb0070) 2002; 96
Salehi, Agur, Scheithauer, Kovacs, Lloyd, Cusimano (bb0005) 2009; 65
Turner, Nagy, Gatter, Esiri, Wass, Harris (bb0035) 2000; 82
Hentschel, McCutcheon, Moore, Durity (bb0020) 2003; 30
Ferrante, Ferraroni, Castrignanò (bb0105) 2006; 155
Kaplan, Meier (bb0140) 1958; 53
Lloyd (10.1016/j.humpath.2011.12.003_bb0120) 2001; 54
Hsu (10.1016/j.humpath.2011.12.003_bb0135) 1993; 78
Mastronardi (10.1016/j.humpath.2011.12.003_bb0090) 1999; 52
Noh (10.1016/j.humpath.2011.12.003_bb0075) 2009; 94
Salehi (10.1016/j.humpath.2011.12.003_bb0005) 2009; 65
Losa (10.1016/j.humpath.2011.12.003_bb0080) 2000; 47
Scarpa (10.1016/j.humpath.2011.12.003_bb0125) 2010; 23
Al-Shraim (10.1016/j.humpath.2011.12.003_bb0150) 2006; 111
Kleinschmidt-DeMasters (10.1016/j.humpath.2011.12.003_bb0155) 2006; 111
Filippella (10.1016/j.humpath.2011.12.003_bb0040) 2006; 65
Lloyd (10.1016/j.humpath.2011.12.003_bb0010) 2004
Hentschel (10.1016/j.humpath.2011.12.003_bb0020) 2003; 30
Gejman (10.1016/j.humpath.2011.12.003_bb0060) 2008; 39
Pizarro (10.1016/j.humpath.2011.12.003_bb0025) 2004; 37
Auer (10.1016/j.humpath.2011.12.003_bb0110) 1985; 7
Jaffrain-Rea (10.1016/j.humpath.2011.12.003_bb0045) 2002; 9
Dubois (10.1016/j.humpath.2011.12.003_bb0015) 2007; 157
Ferrante (10.1016/j.humpath.2011.12.003_bb0105) 2006; 155
Turner (10.1016/j.humpath.2011.12.003_bb0035) 2000; 82
Nakabayashi (10.1016/j.humpath.2011.12.003_bb0050) 2001; 49
Asa (10.1016/j.humpath.2011.12.003_bb0115) 2008; 132
Ogawa (10.1016/j.humpath.2011.12.003_bb0085) 2009; 32
Breiman (10.1016/j.humpath.2011.12.003_bb0145) 1984
Scheithauer (10.1016/j.humpath.2011.12.003_bb0030) 2006; 59
Fusco (10.1016/j.humpath.2011.12.003_bb0065) 2008; 93
Wang (10.1016/j.humpath.2011.12.003_bb0100) 2010; 56
Wierinckx (10.1016/j.humpath.2011.12.003_bb0095) 2007; 14
Kaplan (10.1016/j.humpath.2011.12.003_bb0140) 1958; 53
Knosp (10.1016/j.humpath.2011.12.003_bb0130) 1989; 25
Paek (10.1016/j.humpath.2011.12.003_bb0055) 2005; 20
Meij (10.1016/j.humpath.2011.12.003_bb0070) 2002; 96
References_xml – volume: 94
  start-page: 4406
  year: 2009
  end-page: 4413
  ident: bb0075
  article-title: Predicting recurrence of nonfunctioning pituitary adenomas
  publication-title: J Clin Endocrinol Metab
– volume: 59
  start-page: 341
  year: 2006
  end-page: 353
  ident: bb0030
  article-title: Pathobiology of pituitary adenomas and carcinomas
  publication-title: Neurosurgery
– volume: 30
  start-page: 215
  year: 2003
  end-page: 219
  ident: bb0020
  article-title: P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas
  publication-title: Can J Neurol Sci
– volume: 82
  start-page: 1441
  year: 2000
  end-page: 1445
  ident: bb0035
  article-title: Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumor behaviour
  publication-title: Br J Cancer
– volume: 39
  start-page: 758
  year: 2008
  end-page: 766
  ident: bb0060
  article-title: Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas
  publication-title: H
– volume: 93
  start-page: 2746
  year: 2008
  end-page: 2750
  ident: bb0065
  article-title: Prognostic significance of the Ki-67 labeling index in growth hormone–secreting pituitary adenomas
  publication-title: J Clin Endocrinol Metab
– volume: 65
  start-page: 536
  year: 2006
  end-page: 543
  ident: bb0040
  article-title: Pituitary tumor transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study
  publication-title: Clin Endocrinol
– volume: 32
  start-page: 581
  year: 2009
  end-page: 584
  ident: bb0085
  article-title: Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%
  publication-title: Endocrinol Invest
– volume: 155
  start-page: 823
  year: 2006
  end-page: 829
  ident: bb0105
  article-title: Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors
  publication-title: Eur J Endocrinol
– volume: 25
  start-page: 927
  year: 1989
  end-page: 930
  ident: bb0130
  article-title: Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67
  publication-title: Neurosurgery
– year: 1984
  ident: bb0145
  article-title: Classification and regression trees
– volume: 157
  start-page: 141
  year: 2007
  end-page: 147
  ident: bb0015
  article-title: Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery
  publication-title: Eur J Endocrinol
– start-page: 10
  year: 2004
  end-page: 47
  ident: bb0010
  article-title: Tumors of the pituitary
  publication-title: World Health Organization classification of tumors: pathology and genetics: tumors of endocrine organs
– volume: 78
  start-page: 753
  year: 1993
  end-page: 761
  ident: bb0135
  article-title: Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence
  publication-title: J Neurosurg
– volume: 65
  start-page: 429
  year: 2009
  end-page: 437
  ident: bb0005
  article-title: Ki-67 in pituitary neoplasms: a review—part I
  publication-title: Neurosurgery
– volume: 14
  start-page: 887
  year: 2007
  end-page: 900
  ident: bb0095
  article-title: A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
  publication-title: Endocr Relat Cancer
– volume: 132
  start-page: 1231
  year: 2008
  end-page: 1240
  ident: bb0115
  article-title: Practical pituitary pathology: what does the pathologist need to know?
  publication-title: Arch Pathol Lab Med
– volume: 56
  start-page: 501
  year: 2010
  end-page: 509
  ident: bb0100
  article-title: Increased expression of HMGA1 correlates with tumor invasiveness and proliferation in human pituitary adenomas
  publication-title: Histopathology
– volume: 47
  start-page: 1313
  year: 2000
  end-page: 1318
  ident: bb0080
  article-title: Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results
  publication-title: Neurosurgery
– volume: 20
  start-page: 489
  year: 2005
  end-page: 494
  ident: bb0055
  article-title: Clinical significance of Ki-67 labeling index in pituitary macroadenoma
  publication-title: J Korean Med Sci
– volume: 111
  start-page: 1
  year: 2006
  end-page: 7
  ident: bb0150
  article-title: The 2004 World Health Organization classification of pituitary tumors: what is new?
  publication-title: Acta Neuropathol
– volume: 23
  start-page: 824
  year: 2010
  end-page: 833
  ident: bb0125
  article-title: Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
  publication-title: Mod Pathol
– volume: 9
  start-page: 103
  year: 2002
  end-page: 113
  ident: bb0045
  article-title: A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumors: secreting versus non-secreting adenomas
  publication-title: Endocr Relat Cancer
– volume: 37
  start-page: 235
  year: 2004
  end-page: 243
  ident: bb0025
  article-title: Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody
  publication-title: Braz J Med Biol Res
– volume: 52
  start-page: 107
  year: 1999
  end-page: 111
  ident: bb0090
  article-title: Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody
  publication-title: J Clin Pathol
– volume: 49
  start-page: 1193
  year: 2001
  end-page: 1194
  ident: bb0050
  article-title: Immunohistochemical analyses of cell cycle–related proteins, apoptosis, and proliferation in pituitary adenomas
  publication-title: J Histochem Cytochem
– volume: 54
  start-page: 111
  year: 2001
  end-page: 119
  ident: bb0120
  article-title: Molecular pathology of pituitary adenomas
  publication-title: J Neurooncol
– volume: 111
  start-page: 84
  year: 2006
  end-page: 85
  ident: bb0155
  article-title: Subtyping does matter in pituitary adenomas
  publication-title: Acta Neuropathol
– volume: 96
  start-page: 195
  year: 2002
  end-page: 208
  ident: bb0070
  article-title: The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery
  publication-title: J Neurosurg
– volume: 7
  start-page: 153
  year: 1985
  end-page: 160
  ident: bb0110
  article-title: The first 100 transsphenoidally operated pituitary adenomas in a non-specialised centre: surgical results and tumor-recurrence
  publication-title: Neurol Res
– volume: 53
  start-page: 457
  year: 1958
  end-page: 481
  ident: bb0140
  article-title: Nonparametric estimation from incomplete observations
  publication-title: J Am Stat Assoc
– volume: 14
  start-page: 887
  year: 2007
  ident: 10.1016/j.humpath.2011.12.003_bb0095
  article-title: A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
  publication-title: Endocr Relat Cancer
  doi: 10.1677/ERC-07-0062
– start-page: 10
  year: 2004
  ident: 10.1016/j.humpath.2011.12.003_bb0010
  article-title: Tumors of the pituitary
– volume: 37
  start-page: 235
  year: 2004
  ident: 10.1016/j.humpath.2011.12.003_bb0025
  article-title: Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody
  publication-title: Braz J Med Biol Res
  doi: 10.1590/S0100-879X2004000200011
– volume: 59
  start-page: 341
  year: 2006
  ident: 10.1016/j.humpath.2011.12.003_bb0030
  article-title: Pathobiology of pituitary adenomas and carcinomas
  publication-title: Neurosurgery
  doi: 10.1227/01.NEU.0000223437.51435.6E
– volume: 23
  start-page: 824
  year: 2010
  ident: 10.1016/j.humpath.2011.12.003_bb0125
  article-title: Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2010.58
– volume: 111
  start-page: 1
  year: 2006
  ident: 10.1016/j.humpath.2011.12.003_bb0150
  article-title: The 2004 World Health Organization classification of pituitary tumors: what is new?
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-005-1093-6
– volume: 56
  start-page: 501
  year: 2010
  ident: 10.1016/j.humpath.2011.12.003_bb0100
  article-title: Increased expression of HMGA1 correlates with tumor invasiveness and proliferation in human pituitary adenomas
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2010.03495.x
– volume: 94
  start-page: 4406
  year: 2009
  ident: 10.1016/j.humpath.2011.12.003_bb0075
  article-title: Predicting recurrence of nonfunctioning pituitary adenomas
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-0471
– volume: 111
  start-page: 84
  year: 2006
  ident: 10.1016/j.humpath.2011.12.003_bb0155
  article-title: Subtyping does matter in pituitary adenomas
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-005-1105-6
– volume: 53
  start-page: 457
  year: 1958
  ident: 10.1016/j.humpath.2011.12.003_bb0140
  article-title: Nonparametric estimation from incomplete observations
  publication-title: J Am Stat Assoc
  doi: 10.1080/01621459.1958.10501452
– volume: 65
  start-page: 429
  year: 2009
  ident: 10.1016/j.humpath.2011.12.003_bb0005
  article-title: Ki-67 in pituitary neoplasms: a review—part I
  publication-title: Neurosurgery
  doi: 10.1227/01.NEU.0000349930.66434.82
– volume: 30
  start-page: 215
  year: 2003
  ident: 10.1016/j.humpath.2011.12.003_bb0020
  article-title: P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas
  publication-title: Can J Neurol Sci
  doi: 10.1017/S0317167100002614
– volume: 9
  start-page: 103
  year: 2002
  ident: 10.1016/j.humpath.2011.12.003_bb0045
  article-title: A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumors: secreting versus non-secreting adenomas
  publication-title: Endocr Relat Cancer
  doi: 10.1677/erc.0.0090103
– volume: 93
  start-page: 2746
  year: 2008
  ident: 10.1016/j.humpath.2011.12.003_bb0065
  article-title: Prognostic significance of the Ki-67 labeling index in growth hormone–secreting pituitary adenomas
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-0126
– volume: 65
  start-page: 536
  year: 2006
  ident: 10.1016/j.humpath.2011.12.003_bb0040
  article-title: Pituitary tumor transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2006.02630.x
– volume: 20
  start-page: 489
  year: 2005
  ident: 10.1016/j.humpath.2011.12.003_bb0055
  article-title: Clinical significance of Ki-67 labeling index in pituitary macroadenoma
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2005.20.3.489
– volume: 25
  start-page: 927
  year: 1989
  ident: 10.1016/j.humpath.2011.12.003_bb0130
  article-title: Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67
  publication-title: Neurosurgery
  doi: 10.1227/00006123-198912000-00012
– volume: 82
  start-page: 1441
  year: 2000
  ident: 10.1016/j.humpath.2011.12.003_bb0035
  article-title: Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumor behaviour
  publication-title: Br J Cancer
  doi: 10.1054/bjoc.1999.1074
– volume: 49
  start-page: 1193
  year: 2001
  ident: 10.1016/j.humpath.2011.12.003_bb0050
  article-title: Immunohistochemical analyses of cell cycle–related proteins, apoptosis, and proliferation in pituitary adenomas
  publication-title: J Histochem Cytochem
  doi: 10.1177/002215540104900916
– volume: 7
  start-page: 153
  year: 1985
  ident: 10.1016/j.humpath.2011.12.003_bb0110
  article-title: The first 100 transsphenoidally operated pituitary adenomas in a non-specialised centre: surgical results and tumor-recurrence
  publication-title: Neurol Res
  doi: 10.1080/01616412.1985.11739714
– volume: 78
  start-page: 753
  year: 1993
  ident: 10.1016/j.humpath.2011.12.003_bb0135
  article-title: Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence
  publication-title: J Neurosurg
  doi: 10.3171/jns.1993.78.5.0753
– volume: 47
  start-page: 1313
  year: 2000
  ident: 10.1016/j.humpath.2011.12.003_bb0080
  article-title: Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results
  publication-title: Neurosurgery
  doi: 10.1097/00006123-200012000-00009
– volume: 32
  start-page: 581
  year: 2009
  ident: 10.1016/j.humpath.2011.12.003_bb0085
  article-title: Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%
  publication-title: Endocrinol Invest
  doi: 10.1007/BF03346512
– volume: 54
  start-page: 111
  year: 2001
  ident: 10.1016/j.humpath.2011.12.003_bb0120
  article-title: Molecular pathology of pituitary adenomas
  publication-title: J Neurooncol
  doi: 10.1023/A:1012940929072
– volume: 132
  start-page: 1231
  year: 2008
  ident: 10.1016/j.humpath.2011.12.003_bb0115
  article-title: Practical pituitary pathology: what does the pathologist need to know?
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/2008-132-1231-PPPWDT
– volume: 39
  start-page: 758
  year: 2008
  ident: 10.1016/j.humpath.2011.12.003_bb0060
  article-title: Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2007.10.004
– volume: 96
  start-page: 195
  year: 2002
  ident: 10.1016/j.humpath.2011.12.003_bb0070
  article-title: The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery
  publication-title: J Neurosurg
  doi: 10.3171/jns.2002.96.2.0195
– volume: 155
  start-page: 823
  year: 2006
  ident: 10.1016/j.humpath.2011.12.003_bb0105
  article-title: Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.1.02298
– volume: 157
  start-page: 141
  year: 2007
  ident: 10.1016/j.humpath.2011.12.003_bb0015
  article-title: Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-07-0099
– year: 1984
  ident: 10.1016/j.humpath.2011.12.003_bb0145
– volume: 52
  start-page: 107
  year: 1999
  ident: 10.1016/j.humpath.2011.12.003_bb0090
  article-title: Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.52.2.107
SSID ssj0011545
Score 2.284551
Snippet It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of...
Summary It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1627
SubjectTerms Abbreviations
Accuracy
Adult
Area Under Curve
Biological and medical sciences
Biomarkers, Tumor - analysis
Biomarkers, Tumor - metabolism
Classification
Confidence intervals
Disease Progression
Endocrinopathies
Female
Humans
Hypothalamus. Hypophysis. Epiphysis (diseases)
Investigative techniques, diagnostic techniques (general aspects)
Ki-67
Ki-67 Antigen - analysis
Ki-67 Antigen - metabolism
Male
Medical imaging
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
p53
Pathology
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
Pituitary adenoma
Pituitary Neoplasms - classification
Pituitary Neoplasms - metabolism
Pituitary Neoplasms - pathology
Prognosis
ROC Curve
Sensitivity and Specificity
Studies
Tumor Suppressor Protein p53 - analysis
Tumor Suppressor Protein p53 - metabolism
Tumors
Title A classification tree approach for pituitary adenomas
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0046817711004965
https://www.clinicalkey.es/playcontent/1-s2.0-S0046817711004965
https://dx.doi.org/10.1016/j.humpath.2011.12.003
https://www.ncbi.nlm.nih.gov/pubmed/22446019
https://www.proquest.com/docview/1080920036
https://www.proquest.com/docview/1069207743
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED9EQQQRv60fo4Kv3dY2TdPHIcp0zAdR9C2kaYoTmcN1D774t3u3ph1jysSn0S3XpNfL3e-W-wC4wC2DRi9G3wSNj8dS5XtJINBxTX0hEoUGO6Tc4f4d7z6y2-foeQUuq1wYCqu0ur_U6VNtbb9pWW62RoMB5fgyLnych4qeJZwSzRmLScqbX3WYB1WbKbsYMO7R6FkWT-u1-YIsQ6BVVvKkfwWr3lmL9mlzpMbItbxsd_E7Hp3apett2LKA0u2Ua96BFTPchfW-PTLfg6jjakLIFBI0fQsunUO7VS1xF0GrOxoUk0GhPj5dhWqIIob24fH66uGy69leCZ6OwqDwIhUp3-Rt1Y401zo3LM2Yr7RCA2Uy8lI0z0KEDxnP00zotshUKhKTZblGyiA8gNXh-9AcgesjIgtSzUyYCpYrJgyqTc3aJowDzQPmAKs4JLUtJE79LN5kFTH2Ki1jJTFW-gFVIHWgWZONykoaywh4xX5ZpYmiYpOo65cRxj8RmrHdnmPpyzGOlAsi5ICoKeek8C-TNuYkpH5GRJzoM_LYgdNKZORsIQjYE4oP5A6c1z_jDqdjGzU07xMaw3EIwnSc47AUtdnNEZ2hS50c_3_hJ7CBV0EZoHgKq8XHxJwh0CrSxnQnNWCtc9Pr3tFn7_6p9w1JhCfo
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED90AxVE_LZ-zAq-1q1tmqWPQ5T5sT0p-BbSNMUN2cbWPfjfe7emHaKi-NrmmvR6uftd7yMAl7hl0Oi10TdB4-OxRPleHAh0XBNfiFihwQ6pdrjX591ndv8SvazAdVkLQ2mVVvcXOn2hre2VpuVmczIYUI0v48LHeajpWcyjVahTd6qoBvXO3UO3XwUTCCUUgWbuEcGykKc5vHpFriHWKpp50o_B8visryZqc6JmyLisOPHiZ0i6ME2327BlMaXbKZa9AytmtAtrPRs134Oo42oCyZQVtPgQLoWi3bKduIu41Z0M8vkgV9N3V6EmoqShfXi-vXm67nr2uARPR2GQe5GKlG-ylmpFmmudGZakzFdaoY0yKTkqmqchIoiUZ0kqdEukKhGxSdNMI2UQHkBtNB6ZI3B9BGVBopkJE8EyxYRBzalZy4TtQPOAOcBKDklte4nTkRZvskwaG0rLWEmMlX5ATUgduKrIJkUzjd8IeMl-WVaKom6TqO5_I2x_R2hmdofOpC9nOFJ-kSIHREX5SRD_Mmnjk4RU74igE91G3nbgtBQZuVwIYvaYUgS5AxfVbdzkFLlRIzOe0xiOQxCp4xyHhagtH44ADb3q-Pj_Cz-H9e5T71E-3vUfTmAD7wRFvuIp1PLp3Jwh7sqTht1XHxHAKPY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+classification+tree+approach+for+pituitary+adenomas&rft.jtitle=Human+pathology&rft.au=Righi%2C+Alberto%2C+MD&rft.au=Agati%2C+Patrizia%2C+BSI%2C+PhD&rft.au=Sisto%2C+Andrea%2C+BSI&rft.au=Frank%2C+Giorgio%2C+MD&rft.date=2012-10-01&rft.issn=0046-8177&rft.volume=43&rft.issue=10&rft.spage=1627&rft.epage=1637&rft_id=info:doi/10.1016%2Fj.humpath.2011.12.003&rft.externalDBID=ECK1-s2.0-S0046817711004965&rft.externalDocID=1_s2_0_S0046817711004965
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00468177%2FS0046817712X00091%2Fcov150h.gif